---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-032817"
form_type: "8-K"
ticker: "NGNE"
cik: "0001404644"
company_name: "Neurogene Inc."
filed_at: "2023-09-22T23:59:59+00:00"
generated_at: "2026-06-10T09:36:23.077278+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Neoleukin Therapeutics to effect 1-for-5 reverse stock split on Sept 25 to regain Nasdaq compliance

## Summary
- Reverse stock split at 1-for-5 ratio effective 12:01 a.m. ET on Sept 25, 2023; ticker NLTX unchanged, new CUSIP 64049K203.
- Purpose: regain compliance with Nasdaq minimum bid price requirement of $1.00 per share.
- Outstanding shares reduced from ~44,026,429 to ~8,805,285; no fractional shares, cash paid in lieu.
- Authorized shares decreased from 100,000,000 to 20,000,000 per Certificate of Amendment filed with Delaware.
- Proportionate adjustments to exercise prices and shares underlying equity awards and pre-funded warrants.

## SEC filing metadata
- accession: 0001628280-23-032817
- form_type: 8-K
- ticker: NGNE
- cik: 0001404644
- company_name: Neurogene Inc.
- filed_at: 2023-09-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404644/000162828023032817/0001628280-23-032817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404644/000162828023032817/nltx-20230922.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-032817
- JSON: https://secwatch.observer/filing/0001628280-23-032817.json
- Plain text: https://secwatch.observer/filing/0001628280-23-032817.txt

## Key facts
- Governance Changes
  Neurogene Inc.: Implemented a one-for-five reverse stock split and decreased authorized common shares from 100,000,000 to 20,000,000 (effective 2023-09-25).
  - Change: charter amendment
  - Effective: 2023-09-25
  source text: the Company filed a Certificate of Amendment (the “Amendment”) to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware to implement a one-for-five reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $0.000001 per share (the “Common Stock”) to be effective as of 12:01 am Eastern time on September 25, 2023 (the “Effective Time”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1404644/000162828023032817/0001628280-23-032817-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.